Efficacy and safety of single-agent pan-human epidermal growth factor receptor (HER) inhibitor dacomitinib in locally advanced unresectable or metastatic skin squamous cell cancer
Cavalieri, S., Perrone, F., Miceli, R., Ascierto, P.A., Locati, L.D., Bergamini, C., Granata, R., Alfieri, S., Resteghini, C., Galbiati, D., Busico, A., Paielli, N., Patuzzo, R., Maurichi, A., GallinoТом:
97
Мова:
english
Журнал:
European Journal of Cancer
DOI:
10.1016/j.ejca.2018.04.004
Date:
July, 2018
Файл:
PDF, 1.27 MB
english, 2018